Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion

Kidney International

Volumn 66, Issue 2, 2004, Pages 676-682

  Ferraz, Renato Ribeiro Nogueira ^b   Tiselius, Hans Göran ^b   Heiberg, Ita Pfeferman ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Bile acids; Fat; Hyperoxaluria; Orlistat; Urinary supersaturation

Indexed keywords

CALCIUM; CALCIUM OXALATE; CITRIC ACID; ENZYME INHIBITOR; ION; MAGNESIUM; OXALATE SODIUM; OXALIC ACID; OXALIC ACID DERIVATIVE; SOYBEAN OIL; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL LIPASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM EXCRETION; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXPERIMENTAL MODEL; FAT MALABSORPTION; FEEDING; MAGNESIUM EXCRETION; MALABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STANDARD; TIME; URINALYSIS; URINARY EXCRETION;

EID: 3242774579     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00790.x     Document Type: Article

References (65)

1. PAK CYC: Hyperoxaluric calcium nephrolithiasis, in Urolithiasis: A Medical and Surgical Reference, edited by Resnick MI, Pak CYC, Philadelphia, WB Saunders Company, 1990, pp 65-77
2. KHAN SR: Pathogenesis of oxalate urolithiasis: Lessons from experimental studies with rats. Am J Kidney Dis 12:398-401, 1991
3. BAGGIO B, GAMBARO G: Mechanisms of oxalate cellular transport in idiopathic calcium nephrolithiasis. J Nephrol 11:63-65, 1998
4. WILLIAMS HE, WANDZILAK TR: Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141:742-747, 1989
5. HOLMES RP, GOODMAN HO, ASSIMOS DG: Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270-276, 2001
6. COCHAT P: Primary hyperoxaluria type 1. Kidney Int 55:2533-2547, 1999
7. LEUMANN E, HOPPE B: The primary hyperoxalurias. J Am Soc Nephrol 12:1986-1993, 2001
8. CONYERS RA, BAIS R, ROFE AM: The relation of clinical catastrophes, endogenous oxalate production, and urolithiasis. Clin Chem 36:1717-1730, 1990
9. MARANGELLA M, FRUTTERO B, BRUNO M, LIRIERI F: Hyperoxaluria in idiopathic calcium stone disease: Further evidence of intestinal hyperabsorption of oxalate. Clin Sci 63:381-385, 1982
10. CURHAN GC, WILLETT WC, RIMM EB, STAMPFER MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833-838, 1993
11. MASSEY LK, ROMAN-SMITH H, SUTTON RA: Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc 93:901-906, 1993
12. TAKEI K, ITO H, MASAI M, KOTAKE T: Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria. Urol Int 61:192-195, 1998
13. NISHIURA JL, MENDONÇA COG, SCHOR N, HEILBERG IP: Effect of calcium intake on urinary oxalate excretion in calcium stone-forming patients. Braz J Med Biol Res 35:669-675, 2002
14. EARNEST DL, JOHNSON G, WILLIANS HE: Hyperoxaluria in patients with ileal resection: An abnormality in dietary oxalate absorption. Gastroenterology 66:1114, 1974
15. ANDERSSON H, BOSAEUS I: Hyperoxaluria in malabsorptive states. Urol Int 36:1-9, 1981
16. HICKS K, EVANS GB, ROGERSON ME, BASS P: Jejuno-ileal bypass, enteric hiperoxaluria, and oxalate nephrosis: A role for polarized light in the renal biopsy. J Clin Pathol 51:700-702, 1998
17. MCCONNEL N, CAMPBELL S, GILLANDERS I, et al: Risk factors for developing renal stones in inflammatory bowel disease. BJU Int 89:835-841, 2002
18. RODRIGUEZ REBOLLO T, ARRABAL M, AGUILAR J, PEDRAJAS A: Presence of bile pigments in urinary calculi. Arch Esp Urol 38:567-571, 1985
19. GELLER DA, OSTROW JD, MOORE EW, et al: Binding of calcium by organic anions, determined by perturbation of the equilibrium solubility of [14C] calcium oxalate. Clim Chim Acta 182:255-270, 1989
20. GLEESON D, MURPHY GM, DOWLING RH: Calcium binding by bile acids: in vitro studies using a calcium ion electrode. J Lipid Res 31:781-791, 1990
21. STEINER MS, MORTON RA: Nutritional and gastrointestinal complications of the use of bowel segments in the lower urinary tract. Urol Clin North Am 18:743-754, 1991
22. SASO L, GRIPPA E, GATTO MT, SILVESTRINI B: Inhibition of calcium oxalate precipitation by bile salts. Int J Urol 8:124-127, 2001
23. VASKONEN T: Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem 14:492-506, 2003
24. DOBBINS JW, BINDEN HJ: Effect of bile salts and fatty acids on the colonie absorption of oxalate. Gastroenterology 70:1096-1100, 1976
25. HATCH M, FREEL RW: Alterations in intestinal transport of oxalate in disease states. Scanning Microsc 9:1121-1126, 1995
26. WEIBEL EK, HADVARY P, HOCHULI E, et al: Lipstatin, an inhibitor of pancreatic lipase produced by Streptomyces toxytricini. Producing organism, fermentation, isolation and biological activity. J Antibiot 40:1081-1085, 1987
27. DAVIDSON MH, HAUPTMAN J, DIGIROLAMO M, et al: Weight control and risk factor reduction in obese subjects treated for 2 years with Orlistat. JAMA 281:235-242, 1999
28. WONG NN, CHENG-LAI A: Orlistat. Heart Dis 2:174-181, 2000
29. ACKROFF K, SCLAFANI A: Effects of the lipase inhibitor orlistat on intake and preference for dietary fat in rats. Am J Physiol 271:R48-R54, 1996
30. KALIVIANAKIS M, ELSTRODT J, HAVINGA R, et al: Validation in an animal model of the carbon 13-labeled mixed triglyceride breath test for the detection of intestinal fat malabsorption. J Pediatr 135:444-450, 1999
31. HALLSON PC, ROSE GA: A simplified and rapid enzymatic method for the determination of urinary oxalate. Clin Chim Acta 55:29-39, 1974
32. MCFATE RP, COHN C, EICHELBERGER L, COOPER JA: Symposium on azotemia. Am J Clin Pathol 24:511-571, 1954
33. HOLT C, COWLEY DM, CHALMERS AH: Rapid estimation of urinary citrate by use of a centrifugal analyser. Clin Chem 31:779-780, 1985
34. PHUAPRADIT P, NARANG A, MENDONCA P, et al: The steatocrit: A simple method for estimating stool fat content in newborn infants. Arch Dis Child 56:725-728, 1981
35. COLOMBO C, MAIAVACCA R, RONCHI M, et al: The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 6:926-930, 1987
36. GUARINO A, TARALLO L, GRECO L, et al: Reference values of the steatocrit and its modifications in diarrheal diseases. J Pediatr Gastroenterol Nutr 14:268-274, 1991
37. SUGAI E, SRUR G, VASQUEZ H, et al: Steatocrit: A reliable semiquantitative method for detection of steatorrhea. J Clin Gastroenterol 19:206-209, 1994
38. TISELIUS HG: Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47:255-259, 1991
39. BUSHINSKY DA, KIM M, SESSLER NE, et al: Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45:58-65, 1994
40. WERNESS PG, BROWN CM, SMITH LH, FINLAYSON B: Equil2: A basic computer program for the calculation of urinary saturation. J Urol 134:1242-1244, 1985
41. TISELIUS HG, FERRAZ RRN, HEILBERG IP: An approximate estimate of the ion-activity product of calcium oxalate in rat urine. Urol Res 31:410-413, 2003
42. HESS B, JOST C, ZIPPERLE L: High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241-2247, 1998
43. BUSHINSKY DA, BASHIR MA, RIORDON DR, et al: Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 55:602-612, 1999
44. MENDONÇA COG, MARTINI LA, BAXMANN AC, et al: Effects of an oxalate load on urinary oxalate excretion in calcium stone formers. J Ren Nutr 13:39-46, 2003
45. HEILBERG IP: Update on dietary recommendations and medical treatment of renal stone disease. Nephrol Dial Transplant 15:117-123, 2000
46. CUMMINGS JH, WIGGINS HS, JENKINS DJ, et al: Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion. J Clin Invest 61:953-963, 1978
47. BOTHAM KM, BOYD GS: The effect of dietary fat on bile salt synthesis in rat liver. Biochim Biophys Acta 752:307-314, 1983
48. KNOX R, STEIN I, LEVINSON D, et al: Effect of fat pre-feeding on bile flow and composition in the rat. Biochim Biophys Acta 1083:65-70, 1991
49. HOGAN S, FLEURY A, HADVARY P, et al: Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int J Obes 11:35-42, 1987
50. NISHIOKA T, HAFKAMP AM, HAVINGA R, et al: Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic gunn rats. J Pediatr 143:327-334, 2003
51. VAN DE KAMER JM, HUININK HB, WAYERS HA: Rapid method for the determination of fat in feces. J Biol Chem 177:347-355, 1949
52. MASAI M, ITO H, KOTAKE T: Effect of dietary intake on urinary oxalate excretion in calcium oxalate stone formers. Br J Urol 76:692-696, 1995
53. AL ZAHRANI H, NORMAN RW, THOMPSON C, et al: The dietary habits of idiopathic calcium stone-formers and normal control subjects. BJU Int 85:616-620, 2000
54. NAYA Y, ITO H, MASAI M, YAMAGUCHI K: Association of dietary fatty acids with urinary oxalate excretion in calcium oxalate stone-formers in their fourth decade. BJU Int 89:842-846, 2002
55. MARSHALL RW, COCHRAN M, HODGKINSON A: Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects. Clin Sci 43:91-99, 1972
56. LIEBMAN M, CHAI W: Effect of dietary calcium on urinary oxalate excretion after oxalate loads. Am J Clin Nutr 65:1453-1459, 1997
57. DA SILVA SL, HENNEQUIN C, DROZ D, et al: Influence of various calcium intakes on calcium-oxalate crystalluria in rats on sodium-oxalate diet. Nephrol Dial Transplant 9:1090-1096, 1994
58. RUSHTON HG, SPECTOR M: Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats. J Urol 127:598-604, 1982
59. LIEBMAN M, COSTA G: Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 163:1565-1569, 2000
60. TADAYYON B, LUTWAK L: Interrelationship of triglycerides with calcium, magnesium and phosphorus in the rat. J Nutr 97:246-254, 1968
61. LEMANN JJ, ADAMS ND, GRAY RW: Urinary calcium excretion in human beings. N Engl J Med 301:535-541, 1979
62. MULDOWNEY FP, FREANEY R, MOLONEY MF: Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 22:292-296, 1982
63. MALNIC G, KLOSE RM, GIEBISCH G, SELDIN DW: Micropuncture study of renal potassium excretion in the rat. 1964. J Am Soc Nephrol 11:1354-1369, 2000
64. BUSHINSKY DA, GRYNPAS MD, ASPLIN JR: Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 59:1415-1423, 2001
65. BUSHINSKY DA, ASPLIN JR, GRYNPAS MD, et al: Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975-987, 2002